Baillie Gifford - KITE PHARMA INC ownership

Quarter-by-quarter ownership
Baillie Gifford ownership history of KITE PHARMA INC
ValueSharesWeighting
Q3 2017$495,000
+86.1%
2,754
+7.4%
0.00%
Q2 2017$266,000
+32.3%
2,5640.0%0.00%
Q1 2017$201,0002,5640.00%
Other shareholders
KITE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,358,084$105,736,00048.63%
BAINCO INTERNATIONAL INVESTORS 1,151,540$51,635,0008.76%
Coastal Bridge Advisors, LLC 250,040$11,212,0004.36%
NEXTHERA CAPITAL LP 150,000$6,726,0003.94%
Casdin Capital, LLC 94,000$4,215,0003.48%
MENORA MIVTACHIM HOLDINGS LTD. 1,258,899$56,449,0002.90%
DIALECTIC CAPITAL MANAGEMENT, LP 85,000$3,812,0002.14%
SECTORAL ASSET MANAGEMENT INC 372,223$16,690,0001.85%
ARK Investment Management 97,313$4,364,0001.59%
BB BIOTECH AG 800,000$35,872,0001.33%
View complete list of KITE PHARMA INC shareholders